COVID vaccine live updates: Here’s what to know in North Carolina on Nov. 15
Click here for updates for Nov. 16.
We’re tracking the most up-to-date information about the coronavirus and vaccines in North Carolina. Check back for updates.
More than 1,300 new cases reported
At least 1,506,576 people in North Carolina have tested positive for the coronavirus, and at least 18,437 have died since March 2020, according to state health officials.
The N.C. Department of Health and Human Services on Monday reported 1,361 new COVID-19 cases, down from 1,681 on Sunday and 1,730 on Saturday. The state doesn’t update case counts over the weekends.
There were 26 coronavirus-related deaths added Monday. Health officials don’t specify the dates on which newly reported deaths occurred.
At least 1,039 people were reported hospitalized with COVID-19 as of Monday, including 290 adults being treated in intensive care units, health officials said.
On Saturday, the most recent date with available information, 6.2% of coronavirus tests were reported positive. Health officials say 5% or lower is the target rate to slow the spread of the virus.
Roughly 72% of adults in North Carolina have received at least one dose of a coronavirus vaccine, and about 68% have been fully vaccinated. State officials round vaccination numbers to the nearest whole number.
Lab equipment company to open new NC location
A pharmaceutical services and laboratory equipment company said it plans to build a new manufacturing site in North Carolina.
Thermo Fisher Scientific, which is based in Massachusetts, could bring up to 200 jobs to the Mebane facility, The News & Observer reported. The plan is part of a $192.5 million contract from the U.S. Department of Health and Human Services to help produce “critically needed” products used in labs, according to officials.
“Increased output from recent site expansions is helping meet ongoing demand for COVID-19-related consumables, including plastics used to collect samples and transport them to labs, as well as for vital equipment, such as single-use technologies (SUT), used to accelerate production and allow flexibility for both COVID and non-COVID vaccines and therapies,” Thermo Fisher Scientific said.
This story was originally published November 15, 2021 at 12:16 PM.
